Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based pharmaceutical company. The Company operates four segments. The Pharmaceutical Preparation segment is engaged in the production and sales of anticoagulant and antithrombotic pharmaceutical preparations, including enoxaparin sodium injection and heparin sodium injection. The Active Pharmaceutical Ingredient (API) segment operates the production and sales of API products, including enoxaparin sodium API and heparin sodium API. The contract development manufacturing organization (CDMO) segment provides full-cycle services for the process of developing drugs, including research and development, production, quality management, project management and commercialization. The Company also operates Other segment.

© Copyright 1996-20220232 irasia.com Ltd. All rights reserved.

DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website. TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website.